Hospital
Mount Carmel Health System
Mount Carmel Health System was paid $42.48M by Medicaid between Jan 2018 and Dec 2024, across 311 billing codes. Its largest line is 99284, emergency room visit (serious) — 14% of everything it billed.
33Billing provider infoMOUNT CARMEL HEALTH SYSTEM
WESTERVILLE, OH 43081
WESTERVILLE, OH 43081
33aNPI1417037045assigned 10/17/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$42.48M
24GClaims1,069,571
24DCodes billed311
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Ohio
Rank by total paid#24 of 101
Median peer was paid$22.32M
This provider vs. median1.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 143,672 | $4.82M | |
| 2019 | 134,958 | $4.60M | |
| 2020 | 110,549 | $5.80M | |
| 2021 | 102,901 | $5.14M | |
| 2022 | 111,840 | $4.98M | |
| 2023 | 269,190 | $9.68M | |
| 2024incomplete | 196,461 | $7.46M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 43,260 | 39,113 | $5.82M |
| 96361 | Intravenous infusion, hydration; each additional hour | 14% | 19,781 | 16,615 | $5.77M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 14% | 46,771 | 43,047 | $5.74M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.5% | 25,146 | 21,968 | $3.61M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5.4% | 21,006 | 19,661 | $2.31M |
| 70450 | Computed tomography, head or brain; without contrast material | 4.1% | 6,860 | 5,961 | $1.73M |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 4.0% | 14,607 | 12,032 | $1.71M |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 3.6% | 14,384 | 10,507 | $1.52M |
| 59025 | Fetal non-stress test | 3.5% | 10,346 | 4,644 | $1.50M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.4% | 12,997 | 11,692 | $1.44M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2.7% | 4,241 | 3,611 | $1.16M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.8% | 2,851 | 2,307 | $766K |
299 more codes
| 99213 | Doctor's office visit, returning patient (routine) | 1.7% | 5,435 | $734K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.1% | 2,432 | $485K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 1.1% | 4,171 | $464K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.1% | 12,422 | $454K |
| G0378 | Hospital observation service, per hour | <1% | 5,587 | $413K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 42,047 | $399K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 4,545 | $329K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 2,874 | $316K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 1,063 | $311K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,365 | $263K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 933 | $240K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,050 | $204K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 1,581 | $198K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 1,605 | $185K |
| 93975 | <1% | 1,140 | $181K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 3,117 | $177K |
| 76801 | <1% | 2,423 | $164K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 7,986 | $143K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,871 | $143K |
| 84484 | <1% | 23,314 | $131K | |
| 76820 | <1% | 2,400 | $128K | |
| 81513 | <1% | 908 | $120K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 15,549 | $102K |
| 76642 | <1% | 682 | $92K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 595 | $92K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,809 | $90K |
| 86850 | <1% | 5,194 | $90K | |
| 80076 | <1% | 13,051 | $84K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 1,323 | $82K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 1,084 | $80K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 166 | $75K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 937 | $75K |
| 82805 | <1% | 2,617 | $72K | |
| 86780 | <1% | 4,833 | $72K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 4,939 | $65K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 727 | $63K |
| 80053 | Comprehensive metabolic panel | <1% | 25,675 | $62K |
| 86900 | <1% | 5,231 | $62K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 2,455 | $61K |
| 62323 | <1% | 152 | $59K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 757 | $58K |
| 93971 | <1% | 799 | $52K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,418 | $52K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 376 | $52K |
| 93970 | <1% | 370 | $50K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 4,901 | $49K |
| 70496 | <1% | 228 | $46K | |
| 71045 | Radiologic examination, chest; single view | <1% | 15,505 | $46K |
| 72100 | <1% | 1,378 | $44K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 35,037 | $43K |
| 59430 | <1% | 413 | $40K | |
| 76818 | <1% | 363 | $39K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | <1% | 156 | $36K |
| 97161 | <1% | 987 | $34K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 53,712 | $32K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 2,039 | $30K |
| 93356 | <1% | 1,045 | $30K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 82,721 | $30K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 12,580 | $29K |
| 90715 | <1% | 2,109 | $29K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 99 | $28K |
| 76830 | Ultrasound, transvaginal | <1% | 1,028 | $28K |
| 93017 | <1% | 310 | $28K | |
| 80364 | <1% | 2,394 | $27K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 630 | $27K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,719 | $26K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 28,886 | $24K |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | <1% | 169 | $24K |
| 73560 | <1% | 465 | $22K | |
| 85027 | <1% | 21,214 | $22K | |
| 97165 | <1% | 509 | $22K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 3,960 | $21K |
| 72131 | <1% | 470 | $19K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 1,310 | $19K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 946 | $19K |
| 73030 | <1% | 1,035 | $18K | |
| 72050 | <1% | 330 | $18K | |
| 95886 | <1% | 67 | $17K | |
| 86901 | <1% | 5,291 | $16K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 63 | $15K |
| 70486 | <1% | 435 | $15K | |
| 83021 | <1% | 1,211 | $15K | |
| 81001 | <1% | 31,404 | $15K | |
| 12001 | <1% | 101 | $15K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 80 | $14K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 91 | $14K |
| 82105 | <1% | 956 | $13K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,813 | $13K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 10,637 | $13K |
| 72070 | <1% | 377 | $13K | |
| 74018 | <1% | 754 | $12K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 1,596 | $11K |
| 70498 | <1% | 264 | $11K | |
| 72040 | <1% | 217 | $11K | |
| 73630 | <1% | 1,040 | $11K | |
| 82677 | <1% | 603 | $11K | |
| 93325 | <1% | 121 | $11K | |
| 83690 | <1% | 22,790 | $10K | |
| 96376 | <1% | 3,489 | $10K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 775 | $10K |
| 83735 | <1% | 13,087 | $10K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 4,952 | $10K |
| 77062 | <1% | 233 | $9K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 6,876 | $9K |
| 83605 | <1% | 3,493 | $9K | |
| 73610 | <1% | 822 | $9K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 17,678 | $9K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 14 | $8K |
| 83880 | <1% | 4,483 | $8K | |
| 10060 | <1% | 48 | $8K | |
| 73502 | <1% | 508 | $8K | |
| 0042T | <1% | 38 | $7K | |
| 84702 | <1% | 3,233 | $7K | |
| 73130 | <1% | 728 | $7K | |
| 64635 | <1% | 16 | $7K | |
| 73564 | <1% | 845 | $7K | |
| 77061 | <1% | 231 | $7K | |
| 97116 | <1% | 354 | $7K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 65 | $7K |
| 90658 | <1% | 890 | $7K | |
| 73110 | <1% | 465 | $6K | |
| 76536 | <1% | 53 | $6K | |
| 82950 | <1% | 2,097 | $6K | |
| 71250 | <1% | 59 | $5K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 3,047 | $5K |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 127 | $5K |
| 82248 | <1% | 5,650 | $5K | |
| 70491 | <1% | 13 | $5K | |
| 36430 | <1% | 120 | $5K | |
| 76770 | <1% | 33 | $4K | |
| 94060 | <1% | 29 | $4K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 27,109 | $4K |
| 80349 | <1% | 432 | $4K | |
| 77066 | Tomosynthesis, mammo | <1% | 256 | $3K |
| 77065 | Tomosynthesis, mammo | <1% | 282 | $3K |
| 97162 | <1% | 178 | $3K | |
| 94762 | <1% | 126 | $3K | |
| 84703 | <1% | 5,412 | $3K | |
| 81002 | <1% | 12,785 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,676 | $3K |
| 73590 | <1% | 287 | $2K | |
| 82077 | <1% | 2,052 | $2K | |
| 84145 | <1% | 1,227 | $2K | |
| 85379 | <1% | 1,615 | $2K | |
| 85610 | <1% | 4,342 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,715 | $2K |
| 20610 | <1% | 17 | $2K | |
| 81003 | <1% | 5,759 | $2K | |
| 86787 | <1% | 2,313 | $2K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 121 | $2K |
| 81025 | <1% | 4,803 | $2K | |
| 94729 | <1% | 29 | $2K | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 739 | $2K |
| 93922 | <1% | 30 | $2K | |
| 94726 | <1% | 27 | $2K | |
| 87905 | <1% | 326 | $2K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 3,421 | $2K |
| 82728 | <1% | 1,599 | $2K | |
| 86762 | <1% | 2,193 | $2K | |
| 87481 | <1% | 905 | $2K | |
| 71101 | <1% | 136 | $2K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 965 | $1K |
| 87077 | <1% | 1,534 | $1K | |
| 86701 | <1% | 1,843 | $1K | |
| 87040 | <1% | 1,348 | $1K | |
| 87340 | <1% | 2,250 | $1K | |
| 73562 | <1% | 12 | $1K | |
| J1815 | Injection, insulin, per 5 units | <1% | 1,970 | $1K |
| 99152 | <1% | 94 | $1K | |
| 87081 | <1% | 1,749 | $1K | |
| 73080 | <1% | 138 | $1K | |
| 86140 | <1% | 381 | $1K | |
| 85730 | <1% | 2,152 | $1K | |
| 90688 | <1% | 59 | $1K | |
| 84439 | <1% | 539 | $1K | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | <1% | 346 | $981.41 |
| 87186 | <1% | 1,255 | $967.64 | |
| 86920 | <1% | 81 | $937.33 | |
| 80143 | <1% | 911 | $834.44 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 356 | $799.20 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 1,115 | $766.65 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,093 | $763.75 |
| 82607 | <1% | 214 | $748.84 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 12,532 | $723.26 |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 449 | $722.57 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 2,900 | $700.75 |
| 85652 | <1% | 478 | $686.21 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 429 | $679.12 |
| 80061 | Lipid panel | <1% | 249 | $658.27 |
| 92610 | <1% | 36 | $656.60 | |
| 86803 | <1% | 456 | $656.09 | |
| 73140 | <1% | 34 | $638.70 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,904 | $590.87 |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 434 | $487.20 |
| 72128 | <1% | 46 | $483.11 | |
| 84100 | <1% | 374 | $457.14 | |
| 82947 | <1% | 844 | $438.30 | |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | <1% | 36 | $412.54 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 1,007 | $404.26 |
| 87634 | <1% | 134 | $385.01 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 16,664 | $363.53 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 830 | $359.31 |
| 80179 | <1% | 876 | $328.96 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 5,375 | $311.39 |
| 80320 | <1% | 33 | $307.40 | |
| 82550 | <1% | 262 | $305.50 | |
| 86923 | <1% | 20 | $299.62 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,354 | $289.76 |
| 87070 | <1% | 457 | $276.31 | |
| 73090 | <1% | 71 | $255.59 | |
| 82040 | <1% | 991 | $254.07 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 1,460 | $243.72 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,413 | $226.77 |
| 72072 | <1% | 15 | $215.27 | |
| 87808 | <1% | 335 | $209.58 | |
| 80361 | <1% | 315 | $208.86 | |
| 87205 | <1% | 555 | $201.83 | |
| 82746 | <1% | 82 | $196.41 | |
| J2704 | Injection, propofol, 10 mg | <1% | 2,665 | $196.33 |
| 82570 | <1% | 196 | $188.71 | |
| 84156 | <1% | 281 | $181.70 | |
| 84460 | <1% | 1,038 | $168.01 | |
| 82150 | <1% | 901 | $163.81 | |
| 84075 | <1% | 993 | $144.13 | |
| 83540 | <1% | 192 | $142.40 | |
| 82140 | <1% | 153 | $137.74 | |
| 82247 | <1% | 1,028 | $135.19 | |
| 84155 | <1% | 1,015 | $128.46 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,746 | $128.26 |
| 83550 | <1% | 187 | $126.77 | |
| 84450 | <1% | 883 | $117.95 | |
| 82010 | <1% | 119 | $116.75 | |
| 85007 | <1% | 96 | $114.87 | |
| 82977 | <1% | 842 | $110.44 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 886 | $101.27 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,765 | $100.90 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 438 | $99.46 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 175 | $95.17 |
| 86336 | <1% | 609 | $92.93 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 148 | $92.10 |
| 82565 | <1% | 219 | $91.42 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,152 | $82.42 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 1,025 | $81.48 |
| 80365 | <1% | 315 | $80.73 | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 479 | $71.14 |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 342 | $68.71 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 973 | $64.53 |
| 82310 | <1% | 195 | $63.84 | |
| 83020 | <1% | 124 | $59.41 | |
| 82435 | <1% | 200 | $56.81 | |
| 84520 | <1% | 204 | $56.81 | |
| 82374 | <1% | 199 | $56.81 | |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 247 | $50.02 |
| 84295 | <1% | 151 | $43.05 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 12 | $34.30 |
| 72170 | <1% | 17 | $33.88 | |
| 85046 | <1% | 19 | $32.82 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 574 | $30.40 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 1,862 | $28.32 |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 407 | $25.26 |
| J8597 | Antiemetic drug, oral, not otherwise specified | <1% | 365 | $24.45 |
| J2470 | Injection, pantoprazole sodium, 40 mg | <1% | 91 | $22.14 |
| J3411 | Injection, thiamine hcl, 100 mg | <1% | 49 | $21.34 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,530 | $19.25 |
| 84550 | <1% | 40 | $19.03 | |
| J3490 | Unclassified drugs | <1% | 19 | $17.84 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | <1% | 145 | $17.20 |
| J1953 | Injection, levetiracetam, 10 mg | <1% | 54 | $16.05 |
| 81000 | <1% | 56 | $15.31 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | <1% | 66 | $12.10 |
| 83615 | <1% | 14 | $10.13 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 171 | $9.28 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 14 | $2.36 |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 12 | $2.29 |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 150 | $1.40 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 191 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 188 | $0.00 |
| C1769 | Guide wire | 0% | 445 | $0.00 |
| 88342 | 0% | 124 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 126 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 31 | $0.00 |
| J0456 | Injection, azithromycin, 500 mg | 0% | 29 | $0.00 |
| G0475 | Hiv antigen/antibody, combination assay, screening | 0% | 51 | $0.00 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 0% | 47 | $0.00 |
| 88304 | 0% | 65 | $0.00 | |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 48 | $0.00 |
| 76376 | 0% | 981 | $0.00 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 43 | $0.00 |
| H1000 | Prenatal care, at-risk assessment | 0% | 584 | $0.00 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 0% | 28 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 308 | $0.00 |
| Q0114 | Fern test | 0% | 137 | $0.00 |
| 51702 | 0% | 38 | $0.00 | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 0% | 22 | $0.00 |
| 00812 | 0% | 17 | $0.00 | |
| 00811 | 0% | 14 | $0.00 | |
| 96367 | 0% | 34 | $0.00 | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 0% | 21 | $0.00 |
| 00731 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPRIDAY, ANDREW (CHIEF FINANCIAL OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Mount Carmel Health System | Columbus, OH | $66.65M |
| Mount Carmel Health System | Grove City, OH | $14.42M |
| Diley Ridge Medical Center | Canal Winchester, OH | $6.17M |
| Mount Carmel Health System | Columbus, OH | $5.23M |
| Mount Carmel Health System | Columbus, OH | $403K |
| Mount Carmel Health System | Columbus, OH | $318K |
| Mount Carmel Health System | Grove City, OH | $180K |
| Mount Carmel Health System | New Albany, OH | $14K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.